Since 1959, when Albrink and Man suggested that raised concentrations of serum-triglyceride might be related to the pathogenesis of ischaemic heart disease,' several investigators have measured lipids in healthy individuals and those with this disease.2" Clinical studies have established that a raised serum concentration of total cholesterol is an aetiological factor in coronary artery disease.56 Fewer data are available on the possible value of raised concentrations of triglyceride in predicting the occurrence of the disease in apparently healthy men. In a follow up prospective study in Sweden the occurrence of new events of ischaemic heart disease was related to serum triglycerides and cholesterol, which were risk factors for coronary artery disease that were independent of each other. The highest risk of coronary artery disease was associated with a combined increase of those two serum lipids. 7 Follow up studies from other areas in Sweden confirmed that serum triglycerides were a risk factor for ischaemic heart disease.89 There are more recent both primary and secondary prevention studies, in which a beneficial effect was closely related to a reduction of serum triglycerides rather than to the reduction in serum cholesterol.'01' The serum concentration of total cholesterol in Finland is exceptionally high (mean 6-3 mmol/l) even 6 5 mmol/l or higher. In the present study, however, 31-8% patients without disease and 43-00o with disease had total cholesterol concentrations of > 6-5 mmol/l. This non-significant difference between patients with and without disease was equal whatever the different cut off points of total cholesterol (for 0 1 mmol/l intervals between 6-0 and 7 0 mmol). These results show that total cholesterol measurement alone is not a good discriminator.
There are no firm recommendations on triglyceride measurement in risk assessment and treatment for raised triglycerides. Nevertheless, reanalysis of the Framingham data '4 indicated that serum triglycerides are independently predictive of coronary artery disease in patients with low serum concentrations of HDL cholesterol. Serum triglyceride concentrations are probably important in secondary prevention after myocardial infarction, because serum concentrations are higher in such patients" than in healthy individuals. In the Helsinki Heart Study gemfibrozil considerably reduced triglycerides (by 35 o) but only modestly reduced low density lipoprotein (LDL) cholesterol (8%// decrease) and increased HDL cholesterol (10% increase).'0
The effects on serum concentrations of triglycerides, low density lipoprotein cholesterol, and high density lipoprotein cholesterol contributed to a beneficial outcome.
Those treated with cholestyramine in the seven year Lipid Research Clinics study showed mean reductions in plasma concentrations of total and low density lipoprotein cholesterol of 13 and 20% respectively; an average increase of 300 in HDL cholesterol and the slight rise in triglycerides were not significant.'5 A 17% reduction in all definite end points for ischaemic heart disease was seen in the Lipid Research Clinics study and a 34%o reduction in the Helsinki Heart study, in which the greatest relative change in serum lipid Nikkila, Koivula, Niemela, Sisto There is evidence that triglycerides constitute an independently predictive risk factor for ischaemic heart disease in individuals with low serum concentrations of HDL cholesterol.'4 Raised triglycerides are a risk factor for ischaemic heart disease especially in middle aged men.'9 A reduced fibrinolytic capacity was often found in patients with myocardial infarction and hypertriglyceridaemia.20 Moreover, follow up studies showed that hypertriglyceridaemia was an independent risk factor for reinfarction, an association possibly connected with a predisposition to thrombosis through a coexisting high concentration of plasminogen inhibitor.2' Hypertriglyceridaemia is a thrombogenic factor rather than an atherogenic factor.
The findings of this study re-emphasise the importance of hypertriglyceridaemia and reduced HDL cholesterol as risk factors of coronary artery disease. Similar observations were reported in England, where a raised concentration of serum triglycerides was the best discriminator between patients and controls. than in those without disease. A raised triglyceride concentration was a significant discriminator especially in one vessel disease, when patients tended to be young or middle aged, and their total cholesterol did not differ significantly from patients without disease. Patients without disease were significantly less likely to be smokers, to be taking ,B blockers, and to be men than in the other groups (table 2) .
Smoking and selective ft, blockers do not influence serum total cholesterol, but can slightly increase triglycerides and reduce HDL cholesterol. The smaller proportion of men among those with normal findings on coronary angiography could contribute to the higher values of HDL cholesterol. Myocardial infarction and sudden unstable angina pectoris without earlier chest pain were more commonly found in those with one vessel disease than in those with double or triple vessel disease. Also HDL cholesterol alone was a better discriminator than total cholesterol. The best discriminator in this study was a low ratio of HDL cholesterol to total cholesterol.
Total cholesterol does not discriminate between healthy people and patients with coronary artery disease. Before patients with hypercholesterolaemia (> 6-5 mmol/l) are treated HDL cholesterol should be measured. The results of the present study suggest that the ratio of HDL cholesterol to total cholesterol was a better indicator of coronary risk than HDL cholesterol alone, total cholesterol, or triglycerides. Serum triglycerides give a wider discrimination than serum total cholesterol in identifying not only patients with multivessel disease but also those with important single vessel disease.
